SCHEDULE: Commodore Capital Exits Solid Biosciences Stake
Schedule 13G Amendment
Commodore Capital LP and Commodore Capital Master LP have reported a 0.0% beneficial ownership in Solid Biosciences Inc., indicating a full divestment of their previous stake.
Summary
- Commodore Capital LP and Commodore Capital Master LP have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Solid Biosciences Inc.
- As of the event date of June 30, 2025, both reporting persons beneficially own 0.00 shares of Solid Biosciences Inc. common stock, representing 0.0% of the class.
- This filing indicates that the reporting persons no longer hold a reportable beneficial ownership stake in Solid Biosciences Inc.
- The filing was made pursuant to Rule 13d-1(b).
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of a change in beneficial ownership to 0.0%, indicating a complete divestment by the reporting entities. It provides no positive or negative operational or financial information about Solid Biosciences Inc.
Future Outlook
No forward-looking statements or guidance regarding Solid Biosciences Inc.'s operations or financial performance are provided in this filing.
Industry Context
This filing is a routine disclosure of a change in beneficial ownership by an investment firm. It does not provide insights into Solid Biosciences Inc.'s industry trends or competitive landscape, nor does it reflect broader industry movements.
Stakeholder Impact
- Minimal impact on shareholders as this filing merely reports a divestment by a specific investment entity, not a change in the company's fundamentals or strategy. No direct impact on employees, customers, suppliers, or creditors is indicated.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement, indicating the point at which beneficial ownership became 0.0%. |
| 08/14/2025 | Date of signing for the Schedule 13G Amendment No. 1. |
Keywords
Solid Biosciences, SBL, Commodore Capital, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Investment Firm, Divestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.